Patient-Reported Outcomes for Patients with Previously Treated Small Cell Lung Cancer Receiving Tarlatamab: Results from the DeLLphi-301 Phase 2 Trial

Horst Dieter Hummel, Myung Ju Ahn, Fiona Blackhall, Martin Reck, Hiroaki Akamatsu, Suresh S. Ramalingam, Hossein Borghaei, Melissa Johnson, Franziska Dirnberger, Kim Cocks, Shuang Huang, Sujoy Mukherjee, Luis Paz-Ares

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Patient-Reported Outcomes for Patients with Previously Treated Small Cell Lung Cancer Receiving Tarlatamab: Results from the DeLLphi-301 Phase 2 Trial'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science